A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (NETTER-1)
This study is currently recruiting participants.
Verified January 2013 by Advanced Accelerator Applications
Sponsor:
Advanced Accelerator Applications
Collaborator:
Pierrel Research Europe GmbH
Information provided by (Responsible Party):
Advanced Accelerator Applications
ClinicalTrials.gov Identifier:
NCT01578239
First received: April 10, 2012
Last updated: January 18, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2017 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |